WGRX - NASDAQ
Wellgistics Health, Inc.
$0.72
-7.8%Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
At a Glance
Live SnapshotWellgistics Health, Inc. Management Team
Dr. Shafaat Pirani Pharm.D.
Chief Clinical Officer & Executive Vice President of Healthcare Operations
Compensation
$275,000
Mr. Brian Leonard Norton
Chief Executive Officer
Mr. Mark DiSiena CPA, M.B.A.
Chief Financial Officer
Mr. Srinivas Kalla
Chief Information Officer
David Madsen
Chief Operating Officer
Mr. Prashant Patel R.Ph.
Chief Strategy Officer & Vice Chairman of the Board
Compensation
$400,000
Wellgistics Health, Inc. Insider Positioning
During the last 12 months, insiders have sold $180K worth of WGRX shares, with no buying activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
200.0K
180.00K
-180K
-$180K
Top Buyers
No buying activity
Top Sellers
Peterson Michael L
Director
$180K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $180K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Insider Participation
1 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
SEC Filings
WGRX - Filing history and reports
No SEC filings available for WGRX
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.